In addition to the United States, Biogen has asked regulators in Australia, Brazil, Canada, the European Union, Japan and Switzerland to review the drug.The...
And then, of course, there are the inevitable privacy concerns. Kinsa emphasizes that all data provided to the city will be aggregated and anonymized....